Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between mature B-cell neoplasms are lacking. We developed an algorithm-driven classification for these lymphomas by flow cytometry and compared it to the WHO gold standard diagnosis. Overall, 662 samples from 662 patients representing 9 disease categories were analyzed at 9 laboratories using the previously published EuroFlow 5-tube-8-color B-cell chronic lymphoproliferative disease antibody panel. Expression levels of all 26 markers from the panel were plotted by B-cell entity to construct a univariate, fully standardized diagnostic reference library. For multivariate data analysis, we subsequently used canonical correlation analysis of 176 training cas...
Immunophenotypic characterization of B-cell chronic lymphoproliferative disorders (B-CLPD) is becomi...
Background: Flow cytometry has been widely used for the diagnosis of various hematopoietic diseases....
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Abstract Background Distinction between mature B-cell neoplasms can be difficult due to overlapping...
B-cell Non-Hodgkin lymphomas (B-NHL) are a wide and highly heterogeneous group of malignancies, char...
B-cell Non-Hodgkin lymphomas (B-NHL) are a wide and highly heterogeneous group of malignancies, char...
Immunophenotyping is a routine method to evaluate B-cell non-Hodgkin lymphomas. Flow cytometry plays...
Introduction: Chronic B-Cell Lymphoproliferative Disorders (BCLPD) are malignant neoplasms of B lymp...
The goal of this study was to evaluate routine flow cytometric (FC) immunophenotypic markers in diff...
Immunophenotypic characterization of B-cell chronic lymphoproliferative disorders (B-CLPD) is becomi...
Flow cytometry, a powerful tool for the diagnosis of hematolymphoid malignancies including B-cell ly...
Immunophenotypic characterization of B-cell chronic lymphoproliferative disorders (B-CLPD) is becomi...
Background: Flow cytometry has been widely used for the diagnosis of various hematopoietic diseases....
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between matu...
Abstract Background Distinction between mature B-cell neoplasms can be difficult due to overlapping...
B-cell Non-Hodgkin lymphomas (B-NHL) are a wide and highly heterogeneous group of malignancies, char...
B-cell Non-Hodgkin lymphomas (B-NHL) are a wide and highly heterogeneous group of malignancies, char...
Immunophenotyping is a routine method to evaluate B-cell non-Hodgkin lymphomas. Flow cytometry plays...
Introduction: Chronic B-Cell Lymphoproliferative Disorders (BCLPD) are malignant neoplasms of B lymp...
The goal of this study was to evaluate routine flow cytometric (FC) immunophenotypic markers in diff...
Immunophenotypic characterization of B-cell chronic lymphoproliferative disorders (B-CLPD) is becomi...
Flow cytometry, a powerful tool for the diagnosis of hematolymphoid malignancies including B-cell ly...
Immunophenotypic characterization of B-cell chronic lymphoproliferative disorders (B-CLPD) is becomi...
Background: Flow cytometry has been widely used for the diagnosis of various hematopoietic diseases....
An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is cruc...